Skip to main content
. 2021 May 28;97:107828. doi: 10.1016/j.intimp.2021.107828

Table 2.

Primer sequences.

Normal subjects
(n = 20)
Asymptomatic recovered donors
(n = 20)
Non-ICU hospitalized patients
(n = 30)
ICU hospitalized patients
(n = 30)
Age, Years 25–69 (58.5 ± 10.6) 23–66 (56.4 ± 11.6) 24–67 (57.3 ± 10.6) 25–71 (61.2 ± 10.6)
Sex
Men 10 (50%) 10 (50%) 15 (50) 15 (50)
Women 10 (50%) 10 (50%) 15 (50) 15 (50)
White blood cell count × 109/L
<4 1 (5%) 1 (5%) 4 (13.3%) 1 (%) (3.3%)
4–10 17 (85%) 18 (90%) 22 (73.4%) 24 (80%)
>10 2 (10%) 1 (5%) 4 (13.3%) 5 (16.7%)
Lymphocyte count × 109/L
<1·0 3 (15%) 2 (10%) 8 (26.6%) 16 (53.3%)
≥1·0 17 (85%) 18 (90%) 22 (73.4%) 14 (46.7%)
Platelet count
<100 1 (5%) 2 (10%) 8 (26.6%) 12 (40%)
≥100 19 (95%) 18 (90%) 22 (73.4%) 18 (60%)
Fever 24 (80%) 28 (93.3%)
Sore throat 14 (46.7%) 22 (73.4%)
Dyspnea 15 (50%) 23 (76.6%)
Cough 22 (73.4%) 25 (83.3%)
Lactate dehydrogenase, U/L
≤245 18 (90%) 19 (95%) 11 (36.7%) 8 (26.6%)
>245 2 (10%) 1 (5%) 19 (63.3) 22 (73.4%)
C-reactive protein ≥ 10 mg/L 2 (10%) 16 (53.3%) 18 (60%)
Creatinine, μmol/L
≤133 19 (95%) 19 (95%) 6 (20%) 2 (6.7%)
>133 1 (5%) 1 (5%) 24 (80%) 28 (93.3%)
Bilateral involvement of chestradiographs 14 (46.6%) 29 (96.6%)